Fundamentals of 3D printing of pharmaceuticals
Само за регистроване кориснике
2024
Поглавље у монографији (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
With the progress in medicine during the last several decades, it became clear
that the course of the disease and response to applied therapy differ to a great
extent between patients due to differences in genetic, anatomical, and physiological
characteristics of the patients. This brought into question the current
concept of therapy, so-called one size fits all, where similar drug doses have
been prescribed to a huge number of patients, with neglect of interindividual
differences between patients.
Извор:
From Current to Future Trends in Pharmaceutical Technology, 2024, 1-65Издавач:
- Elsevier Inc.
Финансирање / пројекти:
- Министарство науке, технолошког развоја и иновација Републике Србије, институционално финансирање - 200161 (Универзитет у Београду, Фармацеутски факултет) (RS-MESTD-inst-2020-200161)
Институција/група
PharmacyTY - CHAP AU - Medarević, Đorđe AU - Krstić, Mirjana AU - Ibrić, Svetlana PY - 2024 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5607 AB - With the progress in medicine during the last several decades, it became clear that the course of the disease and response to applied therapy differ to a great extent between patients due to differences in genetic, anatomical, and physiological characteristics of the patients. This brought into question the current concept of therapy, so-called one size fits all, where similar drug doses have been prescribed to a huge number of patients, with neglect of interindividual differences between patients. PB - Elsevier Inc. T2 - From Current to Future Trends in Pharmaceutical Technology T1 - Fundamentals of 3D printing of pharmaceuticals SP - 1 EP - 65 DO - 10.1016/B978-0-323-91111-5.00001-9 ER -
@inbook{ author = "Medarević, Đorđe and Krstić, Mirjana and Ibrić, Svetlana", year = "2024", abstract = "With the progress in medicine during the last several decades, it became clear that the course of the disease and response to applied therapy differ to a great extent between patients due to differences in genetic, anatomical, and physiological characteristics of the patients. This brought into question the current concept of therapy, so-called one size fits all, where similar drug doses have been prescribed to a huge number of patients, with neglect of interindividual differences between patients.", publisher = "Elsevier Inc.", journal = "From Current to Future Trends in Pharmaceutical Technology", booktitle = "Fundamentals of 3D printing of pharmaceuticals", pages = "1-65", doi = "10.1016/B978-0-323-91111-5.00001-9" }
Medarević, Đ., Krstić, M.,& Ibrić, S.. (2024). Fundamentals of 3D printing of pharmaceuticals. in From Current to Future Trends in Pharmaceutical Technology Elsevier Inc.., 1-65. https://doi.org/10.1016/B978-0-323-91111-5.00001-9
Medarević Đ, Krstić M, Ibrić S. Fundamentals of 3D printing of pharmaceuticals. in From Current to Future Trends in Pharmaceutical Technology. 2024;:1-65. doi:10.1016/B978-0-323-91111-5.00001-9 .
Medarević, Đorđe, Krstić, Mirjana, Ibrić, Svetlana, "Fundamentals of 3D printing of pharmaceuticals" in From Current to Future Trends in Pharmaceutical Technology (2024):1-65, https://doi.org/10.1016/B978-0-323-91111-5.00001-9 . .